- ANGLE has announced that Professor Stuart Martin from the University of Maryland School of Medicine, USA, will be presenting a webinar describing his breakthrough work using the Parsortix system to test drugs on live circulating tumour cells as was described in the company's announcement on 9 Oct.

The webinar is intended for cancer researchers but is also open to investors and other interested parties.

The details are as follows: 'Microfluidic Cell Tethering Enables Rapid Analysis of Drug Responses in Live Patient CTCs'; 17 Jan from 5 p.m. to 5:50 p.m. UK time.

Participants need to register in advance using the following link:

Story provided by